Most tumor lesions investigated in our study were high-risk prostate lesions with high GS and ISUP classifications, whereas in studies reporting correlations between PSMA uptake and GS and ISUP, groups of benign or very low-risk prostate lesions were also included. The gene discussed is FOLH1; the disease is neoplasm.